retatrutide weight loss study results for loss: shows 30% body weight Retatrutide just delivered the first

GLP-1 medications prescribed for type 2 diabetes, including Ozempic (semaglutide), Mounjaro (tirzepatide), and Victoza (liraglutide), continue to receive coverage under most BCBS plans

The reason for this is unknown, but prolonged exogenous stimulation of hormone-specific receptors may influence endogenous hormonal regulation (17)

Though still investigational, several sham-controlled, randomized clinical trials suggest benefits in mild-to-moderate ED from shockwave therapy

At Atlanta Bariatrics, we offer personalized weight loss and wellness plans that may include these innovative medications

American Association of Clinical Endocrinology and Endocrine Society clinical practice guideline for pharmacological management of obesity

10.1001/arch-neur.64.4.485 55